Your browser doesn't support javascript.
loading
Liver Histology Predicts Liver Regeneration and Outcome in ALPPS: Novel Findings From A Multicenter Study.
Lopez-Lopez, Victor; Linecker, Michael; Caballero-Llanes, Albert; Reese, Tim; Oldhafer, Karl J; Hernandez-Alejandro, Roberto; Tun-Abraham, Mauro; Li, Jun; Fard-Aghaie, Mohammad; Petrowsky, Henrik; Brusadin, Roberto; Lopez-Conesa, Asuncion; Ratti, Francesca; Aldrighetti, Luca; Ramouz, Ali; Mehrabi, Arianeb; Autran Machado, Marcel; Ardiles, Victoria; De Santibañes, Eduardo; Marichez, Arthur; Adam, René; Truant, Stéphanie; Pruvot, Francois-René; Olthof, Pim B; Van Gulick, Thomas M; Montalti, Roberto; Troisi, Roberto I; Kron, Philipp; Lodge, Peter; Kambakamba, Patryk; Hoti, Emir; Martinez-Caceres, Carlos; de la Peña-Moral, Jesus; Clavien, Pierre-Alain; Robles-Campos, Ricardo.
Affiliation
  • Lopez-Lopez V; Department of Surgery and Liver and Pancreas transplantation, Virgen de la Arrixaca Clinic and University Hospital, IMIB, Murcia, Spain.
  • Linecker M; Department of Surgery and Transplantation, University Medical Center Schleswig-Holstein, Campus Kiel, Germany.
  • Caballero-Llanes A; Department of Pathology, Virgen de la Arrixaca Clinic and University Hospital, IMIB, Murcia, Spain.
  • Reese T; Department of Surgery, Division of Liver, Bileduct and Pancreatic Surgery, Asklepios Hospital Barmbek, Hamburg, Germany.
  • Oldhafer KJ; Department of Surgery, Division of Liver, Bileduct and Pancreatic Surgery, Asklepios Hospital Barmbek, Hamburg, Germany.
  • Hernandez-Alejandro R; Department of Surgery, Western University, London, Ontario, Canada.
  • Tun-Abraham M; Department of Surgery, Western University, London, Ontario, Canada.
  • Li J; Division of Transplantation/Hepatobiliary Surgery, Department of Surgery, University of Rochester, NY.
  • Fard-Aghaie M; Department of General, Visceral and Thoracic Surgery, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Petrowsky H; Department of General, Visceral and Thoracic Surgery, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Brusadin R; Department of Surgery and Transplantation, Swiss HPB and Transplant Center, University Hospital Zurich, Zurich, Switzerland.
  • Lopez-Conesa A; Department of Surgery and Liver and Pancreas transplantation, Virgen de la Arrixaca Clinic and University Hospital, IMIB, Murcia, Spain.
  • Ratti F; Department of Surgery and Liver and Pancreas transplantation, Virgen de la Arrixaca Clinic and University Hospital, IMIB, Murcia, Spain.
  • Aldrighetti L; Department of Surgery, Hepatobiliary Surgery Division, IRCCS San Raffaele Hospital, School of Medicine, Milan, Italy.
  • Ramouz A; Department of Surgery, Hepatobiliary Surgery Division, IRCCS San Raffaele Hospital, School of Medicine, Milan, Italy.
  • Mehrabi A; Department of General, Visceral and Transplant Surgery, Heidelberg University Hospital, Heidelberg, Germany.
  • Autran Machado M; Department of General, Visceral and Transplant Surgery, Heidelberg University Hospital, Heidelberg, Germany.
  • Ardiles V; Department of Surgery, Hospital Adventista Silvestre, Rio de Janeiro, RJ, Brazil.
  • De Santibañes E; Department of Surgery, Division of HPB Surgery, Liver Transplant Unit, Italian Hospital Buenos Aires, Argentina.
  • Marichez A; Department of Surgery, Division of HPB Surgery, Liver Transplant Unit, Italian Hospital Buenos Aires, Argentina.
  • Adam R; Centre Hépato-Biliaire, Hôpital Paul Brousse, Villejuif, France.
  • Truant S; Centre Hépato-Biliaire, Hôpital Paul Brousse, Villejuif, France.
  • Pruvot FR; Department of Digestive Surgery and Transplantation, University Hospital, Lille, France.
  • Olthof PB; Department of Digestive Surgery and Transplantation, University Hospital, Lille, France.
  • Van Gulick TM; Department of Surgery, Amsterdam University Medical Centers, Amsterdam, The Netherlands.
  • Montalti R; Department of Surgery, Amsterdam University Medical Centers, Amsterdam, The Netherlands.
  • Troisi RI; Department of Clinical Medicine and Surgery, Federico II University Hospital Naples, Napoli, Italy.
  • Kron P; Department of Clinical Medicine and Surgery, Federico II University Hospital Naples, Napoli, Italy.
  • Lodge P; HPB and Transplant Unit, St. James's University Hospital, Leeds, UK.
  • Kambakamba P; HPB and Transplant Unit, St. James's University Hospital, Leeds, UK.
  • Hoti E; Department of Hepatobiliary Surgery and Liver Transplantation, St. Vincent's University Hospital, Dublin, Ireland.
  • Martinez-Caceres C; Department of Hepatobiliary Surgery and Liver Transplantation, St. Vincent's University Hospital, Dublin, Ireland.
  • de la Peña-Moral J; Investigation Support Platforms, IMIB-Arrixaca, Murcia, Spain.
  • Clavien PA; Department of Pathology, Virgen de la Arrixaca Clinic and University Hospital, IMIB, Murcia, Spain.
  • Robles-Campos R; Department of General, Visceral and Thoracic Surgery, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Ann Surg ; 279(2): 306-313, 2024 Feb 01.
Article in En | MEDLINE | ID: mdl-37487004
ABSTRACT
BACKGROUND AND

AIMS:

Alterations in liver histology influence the liver's capacity to regenerate, but the relevance of each of the different changes in rapid liver growth induction is unknown. This study aimed to analyze the influence of the degree of histological alterations during the first and second stages on the ability of the liver to regenerate.

METHODS:

This cohort study included data obtained from the International ALPPS Registry between November 2011 and October 2020. Only patients with colorectal liver metastases were included in the study. We developed a histological risk score based on histological changes (stages 1 and 2) and a tumor pathology score based on the histological factors associated with poor tumor prognosis.

RESULTS:

In total, 395 patients were included. The time to reach stage 2 was shorter in patients with a low histological risk stage 1 (13 vs 17 days, P ˂0.01), low histological risk stage 2 (13 vs 15 days, P <0.01), and low pathological tumor risk (13 vs 15 days, P <0.01). Regarding interval stage, there was a higher inverse correlation in high histological risk stage 1 group compared to low histological risk 1 group in relation with future liver remnant body weight ( r =-0.1 and r =-0.08, respectively), and future liver remnant ( r =-0.15 and r =-0.06, respectively).

CONCLUSIONS:

ALPPS is associated with increased histological alterations in the liver parenchyma. It seems that the more histological alterations present and the higher the number of poor prognostic factors in the tumor histology, the longer the time to reach the second stage.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Liver Neoplasms / Liver Regeneration Type of study: Clinical_trials / Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Ann Surg Year: 2024 Type: Article Affiliation country: Spain

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Liver Neoplasms / Liver Regeneration Type of study: Clinical_trials / Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Ann Surg Year: 2024 Type: Article Affiliation country: Spain